Dr Katharina Richter is an enthusiastic biomedical scientist, dedicated to improve therapies against antibiotic-resistant bacteria and biofilms. She has global work and research stints in Germany, Switzerland, Denmark, Belgium, The Netherlands, New Zealand and Australia. A trained pharmacist she completed her PhD in medicine & applied microbiology in 2017 and started her own research group in 2019 at the University of Adelaide, Australia. Her group has two priorities: i) developing new treatments against biofilm infections and bringing them from bench to bedside, and ii) improving health literacy of the society by effective science communication through public speaking, science outreach activities and STEM workshops at schools. Katharina collaborates with scientists, clinicians and industry partners to ensure a real life impact of her work. Dr Kasper Kragh obtained his Ph.D. in Health and Medical Sciences from the University of Copenhagen, Denmark. He has worked for over ten years at the Costerton Biofilm Center with a wide range of aspects concerning bacterial biofilm. During his scientific career, Kasper has focused his attention on the use of microscopy in biofilm research and how the phenotype of non-attached biofilm aggregates is involved and influences both pathogenesis and in vitro systems. The study of the mechanisms behind the chronic infectious state of biofilms, in in vivo-like in vitro models and direct infections, has been a red thread throughout his career.